Prostate Carcinoma trials recruiting in California

All Prostate Carcinoma trials nationally

Cities in California

Recruiting trials in California

• 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
  NCT04857502 · Phase: Early Phase 1 · Ages: No age limits stated · Sex: Male · California: Los Angeles
• An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
  NCT07185165 · Phase: Phase 2 · Ages: 18 Years to 90 Years · Sex: Male · California: Los Angeles
• Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy
  NCT05869682 · Phase: Phase 2 · Ages: 60 Years and older · Sex: Male · California: Duarte
• Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
  NCT04763980 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · California: San Francisco
• Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
  NCT07164027 · Phase: Early Phase 1 · Ages: 18 Years to 90 Years · Sex: Male · California: Los Angeles
• Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
  NCT04765150 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · California: Los Angeles
• Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
  NCT05519878 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte
• Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
  NCT06067295 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · California: Los Angeles
• MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial
  NCT07162194 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years and older · Sex: Male · California: Los Angeles
• Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
  NCT07202247 · Phase: Phase 2 · Ages: 30 Years to 79 Years · Sex: Male · California: Duarte
• Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
  NCT05766371 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: San Francisco
• Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)
  NCT06216249 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: Los Angeles
• Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
  NCT04472338 · Phase: Not specified · Ages: 40 Years and older · Sex: Male · California: Duarte, San Francisco
• The Vanguard Study: Testing a New Way to Screen for Cancer
  NCT06995898 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 75 Years · Sex: All (male and female) · California: Pleasanton